The increase in mTORC1/mTORC2 activity in SLE patients is due to stimulation of the secretion of the inflammatory factor IL-21, which reduces autophagy and blocks the differentiation function of CD4+ and CD25+ Tregs. The gene discussed is CD4; the disease is systemic lupus erythematosus.